Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIVE-C-Free: Harvoni with or without Ribavirin in Liver Transplant Recipients
NCT02631772Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jun 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ledipasvir in hepatitis C (HCV), sponsored by Medical University of South Carolina. Started Jun 2016; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02631772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631772.